» Articles » PMID: 18256785

Tumor Necrosis Factor-alpha Enhances DMSO-induced Differentiation of HL-60 Cells Through the Activation of ERK/MAPK Pathway

Overview
Journal Int J Hematol
Specialty Hematology
Date 2008 Feb 8
PMID 18256785
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-alpha, interleukin-4, tumor necrosis factor-alpha (TNF-alpha), and dimethyl sulfoxide (DMSO) as a single agent or in combination with each other. Here, we show that a combination of TNF-alpha with DMSO shows a synergic effect on HL-60 cell differentiation through the activation of ERK pathway. TNF-alpha enhanced CD11b expression and percent of cell population in the G1 phase induced by DMSO, which are hallmarks for HL-60 cell differentiation. Inhibition of ERK pathway abolished the synergic effect of TNF-alpha in combination with DMSO on HL-60 differentiation, but the inhibition NF-kappaB pathway did not. These results suggest that TNF-alpha synergistically increases DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK-signaling pathway.

Citing Articles

Clusterin mediates hydroquinone-induced cytotoxic responses in HL-60 differentiated cells.

Li P, Gong Q, Wang D, Zhang Z, Zhang W Sci Rep. 2024; 14(1):30402.

PMID: 39638872 PMC: 11621340. DOI: 10.1038/s41598-024-82140-0.


Biochemical characterization of the human ubiquitous glucose-6-phosphatase in neutrophil granulocytes.

Ledeczi Z, Nemeth K, Kardon T FEBS Open Bio. 2024; 15(2):285-295.

PMID: 39548727 PMC: 11788743. DOI: 10.1002/2211-5463.13924.


Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity.

Tang Z, Meng S, Song Z, Yang X, Li X, Guo H Mater Today Bio. 2023; 20:100674.

PMID: 37273794 PMC: 10238753. DOI: 10.1016/j.mtbio.2023.100674.


The Rationality of Implementation of Dimethyl Sulfoxide as Differentiation-inducing Agent in Cancer Therapy.

Hoang B, Han B, Fang W, Tran H, Hoang C, Shaw D Cancer Diagn Progn. 2023; 3(1):1-8.

PMID: 36632588 PMC: 9801450. DOI: 10.21873/cdp.10172.


Anti-leukemic principle(s) from seeds induce differentiation of HL-60 cells through ERK/MAPK signalling pathway.

Sharma J, Prabha P, Sharma R, Gupta S, Dixit A Cytotechnology. 2022; 74(5):591-611.

PMID: 36238266 PMC: 9525536. DOI: 10.1007/s10616-022-00547-x.


References
1.
Wen S, Stolarov J, Myers M, Su J, Wigler M, Tonks N . PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci U S A. 2001; 98(8):4622-7. PMC: 31884. DOI: 10.1073/pnas.081063798. View

2.
Mayo M, Baldwin A . The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta. 2000; 1470(2):M55-62. DOI: 10.1016/s0304-419x(00)00002-0. View

3.
Grant S, Bhalla K, WEINSTEIN B, Pestka S, Mileno M, Fisher P . Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation. Biochem Biophys Res Commun. 1985; 130(1):379-88. DOI: 10.1016/0006-291x(85)90428-0. View

4.
Kumakura S, Ishikura H, Tsumura H, Iwata Y, Endo J, Kobayashi S . C-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF alpha-treated HL-60 cells. Leuk Lymphoma. 1996; 23(3-4):383-94. DOI: 10.3109/10428199609054843. View

5.
Mangelsdorf D, Koeffler H, Donaldson C, Pike J, Haussler M . 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984; 98(2):391-8. PMC: 2113084. DOI: 10.1083/jcb.98.2.391. View